Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLGL

Sol-Gel Technologies Ltd

Apr 30 • 12:24PM ET

71.95

+0.55 0.77 %

Healthcare • Biotechnology • Israel • Micro • NASD

Peers: ANAB MCRB MRNS PTGX XAIR PRQR CRBP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.20	Insider Own	59.82%	Shs Outstand	2.79M	Perf Week	-0.48%
Market Cap	235.21M	Forward P/E	-	EPS next Y	-	Insider Trans	7.26%	Shs Float	1.31M	Perf Month	-9.18%
Enterprise Value	212.20M	PEG	-	EPS next Q	-1.84	Inst Own	35.49%	Short Float	1.43%	Perf Quarter	18.24%
Income	-6.13M	P/S	12.13	EPS this Y	-820.27%	Inst Trans	-19.61%	Short Ratio	0.45	Perf Half Y	95.25%
Sales	19.39M	P/B	8.79	EPS next Y	-	ROA	-18.63%	Short Interest	0.02M	Perf YTD	70.74%
Book/sh	8.19	P/C	9.80	EPS next 5Y	-	ROE	-23.72%	52W High	97.97 -26.56%	Perf Year	846.71%
Cash/sh	7.34	P/FCF	-	EPS past 3/5Y	30.15% 29.88%	ROIC	-26.29%	52W Low	4.11 1650.61%	Perf 3Y	100.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	70.92% 17.19%	Gross Margin	-	Volatility	9.83% 8.69%	Perf 5Y	-34.23%
Dividend TTM	-	EV/Sales	10.94	EPS Y/Y TTM	42.09%	Oper. Margin	-39.16%	ATR (14)	7.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.37	Sales Y/Y TTM	68.04%	Profit Margin	-31.60%	RSI (14)	46.64	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.37	EPS Q/Q	48.91%	SMA20	-3.03%	Beta	1.18	Target Price	110.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	150.36%	SMA50	-9.23%	Rel Volume	0.26	Prev Close	71.40
Employees	28	LT Debt/Eq	0.02	Earnings	Mar 11	SMA200	51.50%	Avg Volume	41.61K	Price	71.95
IPO	Feb 01, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	5,051	Change	0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-24	Downgrade	Raymond James	Strong Buy → Outperform	$6 → $4
Oct-21-22	Resumed	Jefferies	Hold	$5.50
Dec-31-19	Reiterated	JMP Securities	Mkt Outperform	$20 → $33
Dec-31-19	Reiterated	H.C. Wainwright	Buy	$23 → $26

Mar-23-26 09:38PM	Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering (GlobeNewswire) -9.28% +20.86%
Mar-19-26 08:53AM	Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 (GlobeNewswire) +8.46%
Mar-12-26 11:55AM	This Under-the-Radar Stock Has Surged 1,300% Over the Past Year (Barchart) -9.52%
Dec-17-25 07:00AM	Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease (GlobeNewswire)
Nov-20-25 07:30AM	Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire)
07:00AM	Loading…
Sep-04-25 07:00AM	Sol-Gel Announces Health Canada Approval of EPSOLAY (GlobeNewswire) +19.66%
Aug-15-25 07:00AM	Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-23-25 07:15AM	Sol-Gel Reports First Quarter 2025 Results (GlobeNewswire)
May-01-25 07:00AM	Sol-Gel Announces Reverse Share Split (GlobeNewswire)
Apr-17-25 08:40AM	Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S. (GlobeNewswire) +14.58%
Nov-20-24 12:00PM	SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know (Zacks)
07:00AM	Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement (GlobeNewswire)
Nov-15-24 08:10AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Sep-17-24 09:55AM	SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
12:00PM	Loading…
Aug-27-24 12:00PM	All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy (Zacks) +10.22%
Aug-17-24 11:27AM	UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Aug-16-24 08:10AM	Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Jul-25-24 07:00AM	Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa (GlobeNewswire) -32.85%
Jul-15-24 07:00AM	Sol-Gel Technologies Announces Management Realignment (GlobeNewswire) -8.13%
May-28-24 07:00AM	Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice (GlobeNewswire)
May-20-24 01:53PM	SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -6.00%
08:10AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-16-24 06:00AM	Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO in the Mainland of China, Hong Kong, Macau, Taiwan and Israel (GlobeNewswire) +5.65%
Apr-01-24 07:00AM	Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve Cream (GlobeNewswire)
Mar-13-24 07:00AM	Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments (GlobeNewswire)
Nov-30-23 07:00AM	Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study (GlobeNewswire)
Nov-28-23 08:06AM	Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 (GlobeNewswire)
07:00AM	Loading…
Nov-09-23 07:00AM	Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-23 06:43AM	Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies (Zacks)
Oct-30-23 10:05AM	3 Generic Drug Stocks to Watch Amid Improving Market Prospects (Zacks)
Aug-30-23 08:00AM	Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-10-23 08:15AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-21-23 06:04AM	Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Top Key Executive Moshe Arkin is the most upbeat insider, and their holdings increased by 15% last week (Simply Wall St.) +6.20%
Jun-06-23 07:30AM	Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada (Business Wire)
Jun-02-23 06:09AM	Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested five years ago (Simply Wall St.)
May-12-23 08:25AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-22-23 08:19AM	Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Invest In Growth (Simply Wall St.)
Mar-22-23 05:43AM	Load Up, Says Raymond James About These 3 Strong Buy Stocks (TipRanks) +14.69%
Mar-20-23 07:00AM	Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference (GlobeNewswire)
Mar-15-23 11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-12-23 08:23AM	Sol-Gel Technologies Full Year 2022 Earnings: Misses Expectations (Simply Wall St.)
Mar-10-23 08:15AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments (GlobeNewswire)
Feb-27-23 06:02AM	Could The Market Be Wrong About Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Its Attractive Financial Prospects? (Simply Wall St.) +6.02%
Feb-23-23 02:32PM	The Top 7 Penny Stocks to Invest in for the Long-Term (InvestorPlace) -6.35%
Jan-27-23 07:29AM	Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings (GlobeNewswire)
07:00AM	Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million (GlobeNewswire)
Dec-08-22 06:16AM	Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies (Zacks)
Dec-07-22 10:52AM	3 Generic Drug Stocks to Watch Amid Inflation Pressures (Zacks)
Nov-10-22 04:00AM	Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-03-22 03:03PM	Sol-Gel Technologies (NASDAQ:SLGL) investors are sitting on a loss of 45% if they invested a year ago (Simply Wall St.)
Oct-03-22 08:00AM	Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development (GlobeNewswire)
Sep-19-22 01:00PM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Sol-Gel Technologies Ltd.'s NASDAQ:SLGL) Stock? (Simply Wall St.)
Sep-12-22 04:30AM	Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Sol-Gel (Zacks)
Sep-09-22 12:13PM	3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure (Zacks)
Aug-04-22 06:00AM	Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -6.64%
Jun-01-22 08:00AM	Sol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference (GlobeNewswire)
May-27-22 11:45AM	Investors in Sol-Gel Technologies (NASDAQ:SLGL) have unfortunately lost 43% over the last year (Simply Wall St.) +6.53%
May-17-22 07:00AM	Sol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-13-22 07:00AM	Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +6.00%
Apr-25-22 07:00AM	Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® (GlobeNewswire) -7.61%
Apr-14-22 08:30AM	Sol-Gel Technologies Announces the Commercial Availability of TWYNEO® (GlobeNewswire) +9.94%
Apr-12-22 11:26AM	Are Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? (Simply Wall St.)
Mar-30-22 07:00AM	Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments (GlobeNewswire)
Mar-25-22 11:00AM	Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA (GlobeNewswire)
Dec-22-21 04:05PM	Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference (GlobeNewswire)
Dec-21-21 07:00AM	Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY® (GlobeNewswire)
Nov-30-21 08:27AM	Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) have lost 23%, as stock drops 12% this past week (Simply Wall St.) +9.10%
Nov-11-21 07:00AM	Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments (GlobeNewswire)
Nov-09-21 07:05AM	Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference (GlobeNewswire)
Nov-04-21 07:30AM	Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million (GlobeNewswire)
Oct-01-21 12:14PM	Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely? (Simply Wall St.)
Sep-22-21 07:30AM	Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference (GlobeNewswire) -6.09%
Sep-09-21 08:30AM	Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-17-21 01:30PM	What Is The Ownership Structure Like For Sol-Gel Technologies Ltd. (NASDAQ:SLGL)? (Simply Wall St.)
Aug-04-21 07:05AM	Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments (GlobeNewswire) -5.67%
Jul-27-21 10:26AM	Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris (Benzinga)
09:15AM	Sol-Gel Technologies Announces FDA Approval of TWYNEO® (GlobeNewswire)
Jul-20-21 07:05AM	Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021 (GlobeNewswire)
Jun-28-21 05:10AM	Sol-Gel Announces Pipeline Update and Future Development Plans (GlobeNewswire) -6.79%
05:00AM	Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States (Business Wire)
May-27-21 07:00AM	Sol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human Health Innovation Conference (GlobeNewswire)
May-18-21 09:27AM	Does Sol-Gel Technologies' (NASDAQ:SLGL) Share Price Gain of 23% Match Its Business Performance? (Simply Wall St.)
May-13-21 07:05AM	Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update (GlobeNewswire) +15.19%
Apr-28-21 08:41PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGL (Newsfile) -6.33%
Apr-27-21 02:20PM	Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sol-Gel Technologies Ltd. (SLGL) Investigation (ACCESSWIRE) -12.66%
10:02AM	Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY® (GlobeNewswire)
Mar-19-21 06:56AM	Sol-Gel Technologies (NASDAQ:SLGL) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Mar-10-21 10:29AM	Raymond James: These 3 Stocks Are Poised to Surge by at Least 50% (TipRanks) +10.79%
Mar-04-21 07:05AM	Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update (GlobeNewswire) -8.42%
Feb-24-21 07:05AM	Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference (GlobeNewswire) -5.24%
Jan-18-21 07:49AM	Have Insiders Been Buying Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares? (Simply Wall St.)
Jan-11-21 07:05AM	Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference (GlobeNewswire)
Dec-07-20 07:05AM	Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris (GlobeNewswire)
Dec-01-20 08:33AM	Sol-Gel Technologies (SLGL) Looks Good: Stock Adds 8.8% in Session (Zacks)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Opaleye Management Inc.	10% Owner	Mar 24 '26	Buy	72.00	39,665	2,855,880	485,000	Mar 24 04:05 PM
Yosef Itzik	Officer	Mar 11 '26	Proposed Sale	88.70	142	12,595		Mar 12 07:11 AM
Yosef Itzik	Officer	Feb 25 '26	Proposed Sale	87.63	1,556	136,352		Feb 26 06:21 AM
Yosef Itzik	Officer	Feb 23 '26	Proposed Sale	83.98	1,170	98,257		Feb 24 07:41 AM
Opaleye Management Inc.	10% Owner	Feb 13 '26	Buy	63.00	291	18,333	450,335	Feb 18 04:05 PM
Opaleye Management Inc.	10% Owner	Feb 02 '26	Buy	58.00	100	5,800	450,944	Feb 04 04:05 PM
Opaleye Management Inc.	10% Owner	Jan 27 '26	Buy	57.05	100	5,705	449,944	Jan 29 04:16 PM
Opaleye Management Inc.	10% Owner	Jan 22 '26	Buy	56.57	2,173	122,922	448,693	Jan 23 05:42 PM
Opaleye Management Inc.	10% Owner	Jan 23 '26	Buy	55.98	1,151	64,434	449,844	Jan 23 05:42 PM
Yosef Itzik	Officer	Jan 14 '26	Proposed Sale	62.94	713	44,876		Jan 15 06:54 AM
Opaleye Management Inc.	10% Owner	Jan 02 '26	Buy	41.92	2,394	100,348	447,133	Jan 06 04:05 PM
Opaleye Management Inc.	10% Owner	Jan 05 '26	Buy	42.98	198	8,510	447,331	Jan 06 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 30 '25	Buy	41.99	35,169	1,476,627	421,242	Dec 31 05:45 PM
Opaleye Management Inc.	10% Owner	Dec 31 '25	Buy	41.99	22,497	944,744	443,739	Dec 31 05:45 PM
Opaleye Management Inc.	10% Owner	Dec 29 '25	Buy	41.85	8,638	361,534	386,073	Dec 31 05:45 PM
Opaleye Management Inc.	10% Owner	Dec 26 '25	Buy	41.68	1,626	67,765	377,435	Dec 29 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 22 '25	Buy	41.15	1,019	41,936	375,549	Dec 29 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 23 '25	Buy	41.66	260	10,832	375,809	Dec 29 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 17 '25	Buy	40.37	2,735	110,412	374,530	Dec 19 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 12 '25	Buy	40.00	87	3,480	371,795	Dec 16 04:05 PM
Opaleye Management Inc.	10% Owner	Dec 05 '25	Buy	39.50	444	17,537	371,408	Dec 09 04:12 PM
Opaleye Management Inc.	10% Owner	Dec 08 '25	Buy	39.77	300	11,932	371,708	Dec 09 04:12 PM
Opaleye Management Inc.	10% Owner	Dec 01 '25	Buy	37.37	4,340	162,167	368,440	Dec 03 05:39 PM
Opaleye Management Inc.	10% Owner	Dec 03 '25	Buy	37.81	2,524	95,443	370,964	Dec 03 05:39 PM
Opaleye Management Inc.	10% Owner	Nov 26 '25	Buy	40.00	943	37,720	364,100	Nov 26 04:05 PM
Opaleye Management Inc.	10% Owner	Nov 24 '25	Buy	35.50	6	213	363,157	Nov 26 04:05 PM
Opaleye Management Inc.	10% Owner	Nov 20 '25	Buy	35.83	5,784	207,244	363,151	Nov 21 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLGL

Sol-Gel Technologies Ltd

Upgrade your Finviz experience